AXL activation promotes adaptive resistance to KRAS-G12C inhibitors in KRASG12C-mutated non-small cell lung cancer

被引：0
作者：
Morimoto, Kenji
Yamada, Tadaaki
Hirai, Soichi
Katayama, Yuki
Kunimasa, Kei
Sasaki, Takaaki
Nishida, Makoto
Watanabe, Satoshi
Shiotsu, Shinsuke
Uehara, Hisanori
Takayama, Koichi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1941
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1941
引用
收藏
页数：2
相关论文
共 50 条
[31]   The immunotherapy role in patients (pt) with KRAS mutated metastatic non-small cell lung cancer (NSCLC): Differences between KRAS G12C and non-G12C [J].
Notario Rincon, L. ;
Pous, A. ;
Lopez-Paradis, A. ;
Cerda, G. ;
Cucurull, M. ;
Hernandez, A. ;
Domenech, M. ;
Carcereny, E. ;
Moran Bueno, M. T. ;
Munoz, A. ;
Mate, J. L. ;
Sanz, C. ;
Saigi, M. .
ANNALS OF ONCOLOGY, 2022, 33 :S50-S50
[32]   Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer [J].
Liu, Hongyu ;
Zhou, Chao ;
Lu, Jun ;
Liu, Yuqing ;
Zou, Peichen ;
Zhu, Liang ;
Lei, Huimin ;
Han, Baohui .
CELL DEATH & DISEASE, 2025, 16 (01)
[33]   AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells [J].
Morimoto, Kenji ;
Yamada, Tadaaki ;
Hirai, Soichi ;
Katayama, Yuki ;
Fukui, Sarina ;
Sawada, Ryo ;
Tachibana, Yusuke ;
Matsui, Yohei ;
Nakamura, Ryota ;
Ishida, Masaki ;
Kawachi, Hayato ;
Kunimasa, Kei ;
Sasaki, Takaaki ;
Nishida, Makoto ;
Furuya, Naoki ;
Watanabe, Satoshi ;
Shiotsu, Shinsuke ;
Nishioka, Naoya ;
Horinaka, Mano ;
Sakai, Toshiyuki ;
Uehara, Hisanori ;
Yano, Seiji ;
Son, Bo-Kyung ;
Tokuda, Shinsaku ;
Takayama, Koichi .
CANCER LETTERS, 2024, 587
[34]   The KRAS-G12C inhibitor: activity and resistance [J].
Jiao Liu ;
Rui Kang ;
Daolin Tang .
Cancer Gene Therapy, 2022, 29 :875-878
[35]   Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer [J].
Ganguly, Arghya ;
Yoo, Euna .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (06) :536-537
[36]   Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors [J].
Marinelli, D. ;
Pisegna, S. ;
Giammaruco, M. ;
Chesi, P. ;
Mammone, G. ;
Ceddia, S. ;
Gazzaniga, P. ;
Cortesi, E. ;
Gelibter, A. J. .
ANNALS OF ONCOLOGY, 2021, 32 :S1345-S1346
[37]   Efficacy of JS']JSI-1187 or VIC-1911 in combination with KRAS G12C inhibitors for the treatment of KRAS G12C-mutated non-small cell lung cancer and colorectal cancer [J].
Zhang, Lei ;
Li, Ao ;
Jian, Shanzhong ;
Du, Chengyi ;
Zhu, Wan ;
Tao, Yue ;
Wang, Meiwei ;
Xu, Wen ;
Hao, Wenshan ;
Paradiso, Linda ;
Myers, Thomas ;
Koya, Keizo ;
Zhang, Jintao .
CANCER RESEARCH, 2023, 83 (07)
[38]   Development of combination therapies to potentiate the impact of KRAS-G12C inhibitors in lung cancer [J].
Molina-Arcas, Miriam ;
Moore, Christopher ;
Rana, Sareena ;
Van Maldegem, Febe ;
Mugarza, Edurne ;
Romero-Clavijo, Pablo ;
Horswell, Stuart ;
Hancock, David ;
Downward, Julian .
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
[39]   The KRAS-G12C inhibitor: activity and resistance [J].
Liu, Jiao ;
Kang, Rui ;
Tang, Daolin .
CANCER GENE THERAPY, 2022, 29 (07) :875-878
[40]   In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer [J].
Kato, Ryoji ;
Solanki, Hitendra S. ;
Ozakinci, Hilal ;
Desai, Bina ;
Gundlapalli, Harika ;
Yang, Yu Chi ;
Aronchik, Ida ;
Singh, Mallika ;
Johnson, Joseph ;
Marusyk, Andriy ;
Boyle, Theresa A. ;
Haura, Eric B. .
CLINICAL CANCER RESEARCH, 2025, 31 (06) :1150-1162
12345